HK Stock MarketDetailed Quotes

HENLIUS (02696)

Watchlist
  • 73.550
  • -4.600-5.89%
Market Closed May 8 16:07 CST
39.97BMarket Cap43.65P/E (TTM)

HENLIUS (02696) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
销售生物制药产品5.77B86.62%
Research and development services619.14M9.29%
授权许可收入257.77M3.87%
Other12.24M0.18%
来自经营租赁的总租金收入2.87M0.04%

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
销售生物制药产品5.77B86.62%
Research and development services619.14M9.29%
授权许可收入257.77M3.87%
Other12.24M0.18%
来自经营租赁的总租金收入2.87M0.04%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
China Mainland5.78B86.73%
North America465.47M6.98%
Europe275.8M4.14%
亚太区(不包括中国大陆)116.01M1.74%
South America27.58M0.41%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More